期刊文献+

慢性阻塞性肺疾病患者医院感染危险因素及病原学分析 被引量:10

Risk factors and etiology of nosocomial infections in patients with chronic obstructive pulmonary diseases
原文传递
导出
摘要 目的探讨慢性阻塞性肺疾病(COPD)患者,医院感染的危险因素及病原学特点。方法采用病例对照的方法,调查2006年7月-2008年8月,在呼吸内科病房发生医院感染的COPD患者,做1∶1配对。结果 COPD患者医院感染的独立危险因素为住院天数(OR=5.838)和留置导管(OR=4.487),而雾化吸入糖皮质激素为保护性因素(OR=0.067);医院感染的部位以下呼吸道多见占78.0%;病原菌中革兰阴性菌占52.3%,革兰阳性菌占35.8%,真菌占11.9%。结论对部分COPD急性加重期患者,雾化吸入糖皮质激素可减少医院感染的发生,加强医务人员的手卫生及规范化操作、严格掌握留置导管指征、尽可能缩短住院天数,对减少医院感染有一定意义。 OBJECTIVE To explore the risk factors and etiology of nosocomial infections in patients with chronic obstructive pulmonary disease.METHODS Retrospective analysis was carried out to investigate the cases of nosocomial infection of patients with chronic obstructive pulmonary disease in the department of respiratory medicine from Jul 2006 to Aug 2008,A 1∶1 matched case control study was conduced.RESULTS The independent risk factors were days of hospitalization(OR=5.838) and indwelling catheters(OR=4.487).Aerosol Inhalation of glucocorticosteroid was a protective factor(OR=0.067).Lower respiratory tract infection was frequent(78.0%).The pathogenic bacteria were mainly Gram-negative bacilli(52.3%) and then Gram-positive cocci(35.8%),fungi(11.9%).CONCLUSION Aerosol inhalation of glucocorticosteroid can reduce the rate of nosocomial infection in some patients with acute exacerbation of COPD.It is also important to emphasize hands hygiene and standardized operation of medical staff,to manage indwelling catheters strictly and reduce the duration of hospitalization as short as possible.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第18期3829-3831,共3页 Chinese Journal of Nosocomiology
基金 上海市嘉定区科委资助课题2006(JKK024)
关键词 慢性阻塞性肺疾病 医院感染 危险因素 糖皮质激素 Chronic obstructive pulmonary diseases Nosocomial infection Risk factors Glucocorticosteroid
作者简介 通讯作者:屠春林,E-mail:tuchunlin@yahoo.com.cn
  • 相关文献

参考文献5

二级参考文献18

共引文献8393

同被引文献81

  • 1游建萍,黄庆,府伟灵,张雪.手卫生所致医院感染的预防和控制措施的探讨[J].中华医院感染学杂志,2005,15(4):426-428. 被引量:379
  • 2况波,邹颖琦.纳洛酮与尼可刹米治疗慢性阻塞性肺疾病急性加重期并发肺性脑病的效果比较[J].实用医院临床杂志,2010,7(4):112-113. 被引量:9
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8257
  • 4黄玉民,陶玉坚,丁寿来,等.沙美特罗替卡松联合噻托溴铵吸入治疗中重度COPD40例疗效观察[J].临床肺科杂志,2011,16(7):1009-1010.
  • 5Lavergne V,Ghannoun M, Weiss Ket al. Successful preven-tion of respiratory syncytial virus nosocomial transmission fol-lowing an enhanced seasonal infectin control program [J].Bone Marrow Transplant,2010.46(1) : 137-142.
  • 6Liu KS,Wang YT, Lai YC,ef al. Antimicrobial resistance ofbacterial isolates from respiratory care wards in Taiwan: ahorizontal surveillance study comparison of the characteristicsof nosocomial infection and antimicrobial-resistan bacteria inadult Intensive Care Unites and two respiratory care facilitiesfor mechanically ventilated patients at a tertiary care centre inTaiwan[J]. Int J Antimicrob Agents,2011,37(1) .10-15.
  • 7Slenter RH,Spr〇oten RT, Kotz D, et al. Predictors of 1-yearmortality at hospital admission for acute exacerbations ofchronic obstructive pulmonary disease [J]. Respiration, 2013,85(1):15-26.
  • 8Alfageme I,Reyes N,Merino M,et al. The effect of airflowlimitation on the cause of death in patients with COPD[J].Chron Respir Dis,2010,7(3) : 135-145.
  • 9Deng ZC,Zhao P,Cao C,et al. C-reactive protein as aprognostic marker in chronic obstructive pulmonary disease[J]. Exp Ther Med,20H,7(2) :443-446.
  • 10Antonescu-Turcu AL,Tomic R. C-reactive protein andcopeptin: prognostic predictors in chronic obstructivepulmonary disease exacerbations [J]. Curr Opin Pulm Med,2009,15(2):120-125.

引证文献10

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部